The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
- PMID: 11193145
- DOI: 10.1111/j.1749-6632.2000.tb06900.x
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
Abstract
Parkinson's disease is the second most common neurodegenerative disease, after Alzheimer's disease. Neuropathologically, it is characterized by the degeneration of populations of nerve cells that develop filamentous inclusions in the form of Lewy bodies and Lewy neurites. Recent work has shown that the filamentous inclusions of Parkinson's disease are made of the protein alpha-synuclein and that rare, familial forms of Parkinson's disease are caused by missense mutations in the alpha-synuclein gene. Besides Parkinson's disease, the filamentous inclusions of two additional neurodegenerative diseases, namely, dementia with Lewy bodies and multiple system atrophy, have also been found to be made of alpha-synuclein. Recombinant alpha-synuclein has been shown to assemble into filaments with similar morphologies to those found in the human diseases and with a cross-beta fiber diffraction pattern. The new work has established the alpha-synucleinopathies as a major class of neurodegenerative disease.
Similar articles
-
Parkinson's disease and other alpha-synucleinopathies.Clin Chem Lab Med. 2001 Apr;39(4):308-12. doi: 10.1515/CCLM.2001.047. Clin Chem Lab Med. 2001. PMID: 11388653 Review.
-
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.Neurosci Lett. 1998 Jul 31;251(3):205-8. doi: 10.1016/s0304-3940(98)00504-7. Neurosci Lett. 1998. PMID: 9726379
-
[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6. Rinsho Shinkeigaku. 1999. PMID: 10791099 Japanese.
-
Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.Acta Neuropathol. 2002 Sep;104(3):225-30. doi: 10.1007/s00401-002-0546-4. Epub 2002 May 9. Acta Neuropathol. 2002. PMID: 12172907
-
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.
Cited by
-
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.Brain Pathol. 2023 Jan;33(1):e13112. doi: 10.1111/bpa.13112. Epub 2022 Aug 24. Brain Pathol. 2023. PMID: 36054524 Free PMC article.
-
α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model.PLoS Pathog. 2024 Sep 12;20(9):e1012517. doi: 10.1371/journal.ppat.1012517. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39264912 Free PMC article.
-
splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants.Cells. 2019 Sep 12;8(9):1072. doi: 10.3390/cells8091072. Cells. 2019. PMID: 31547305 Free PMC article.
-
Alpha-synuclein expression modulates microglial activation phenotype.J Neurosci. 2006 Oct 11;26(41):10558-63. doi: 10.1523/JNEUROSCI.1799-06.2006. J Neurosci. 2006. PMID: 17035541 Free PMC article.
-
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy.J Parkinsons Dis. 2023;13(2):179-196. doi: 10.3233/JPD-225055. J Parkinsons Dis. 2023. PMID: 36744345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous